Amgen: An Attractive Investment in an Uncertain Market
Amgen reported strong results in the second quarter with robust performance from its innovative biologics and biosimilars portfolio.
Reading Time: 1 minute
Amid the turbulence in the financial markets, investors are looking for stable yet growth-oriented companies. The stock of biopharma giant Amgen (i) could be an interesting option here. Several factors currently favor an investment. Amgen has reported solid financial results and raised its annual forecast. The company is growing steadily and generating impressive cash flow. This allows it to pay an attractive dividend, which is particularly appealing to income-focused investors. With the acquisition of Horizon Therapeutics, Amgen has strategically...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
